News: Search Results
The U.S. Supreme Court on Thursday upheld the majority of the tenets of the Affordable Care Act. CCFA and its members have advocated for insurance reforms supporting increased access to care and therapies for all people with IBD and their families. The reforms in the Affordable Care Act reflect this important work.
According to the newest data presented at the 2012 DDW, there is no increased risk of birth defects among newborns of women who take certain biologic or immunomodulator therapy to control their Inflammatory Bowel Disease.
Bridgestone Americas, Inc CEO & President Gary A. Garfield Named First Ever National Take Steps Be Heard Walk ChairmanApril 30, 2012
The Crohn’s & Colitis Foundation of America (CCFA) is delighted to announce that Gary Garfield, President & CEO of Bridgestone Americas, Inc, will serve as the organization’s first ever National Chair for their Take Steps Be Heard walk program.
The Crohn’s & Colitis Foundation of America Named National Charity Beneficiary of the Lady Speed Stick® Women’s Half Marathon-NashvilleApril 2, 2012
The Crohn’s & Colitis Foundation of America has signed on as the National Beneficiary of the Lady Speed Stick® Women’s Half Marathon presented by Publix held in Nashville, Tennessee on Saturday, September 22, 2012.
The Crohn’s & Colitis Foundation of America Announces New National Board of Trustees Chair and Three New MembersMarch 6, 2012
The Crohn’s & Colitis Foundation of America (CCFA) is delighted to announce Maura C. Breen as its new National Board of Trustees Chair along with Donald Burke, John Crosson and Matt Leavitt, D.O., FAOCD as new members of the board.
Crohn’s & Colitis Foundation Honors Three Scientific Leaders for Exceptional Contributions to Field of Inflammatory Bowel DiseasesDecember 2, 2011
The Crohn’s & Colitis Foundation of America is proud to honor three leaders in the field of IBD research and treatment on Friday, December 2nd at its 2011 Advances in Inflammatory Bowel Diseases Clinical & Research Conference in Hollywood, Florida.
The week of December 1-7 has been designated by the Crohn’s & Colitis Foundation of America (CCFA) as Crohn’s and Colitis Awareness Week in order to encourage all Americans to join in the effort to find cures for these diseases, help raise awareness and support research.
According to the newest data presented at the 2011 Advances in Inflammatory Bowel Diseases Crohn’s & Colitis Foundation’s Clinical & Research Conference, the benefits of treating Inflammatory Bowel Disease (IBD) with the latest therapies outweigh the slightly increased risk associated with cancer.
Congressional Crohn’s and Colitis Caucus Co-Chairmen Rep. Ander Crenshaw (R-FL) and Rep. Jesse Jackson, Jr., (D-IL) today (10/7) announced that the Caucus will hold its kick-off briefing on Wednesday, October 12.
ohnson & Johnson's Stelara helped a significantly higher percentage of Crohn's disease sufferers than those who received a placebo, according to a study of patients who had not been helped by other commonly used drugs.
The U.S. Food and Drug Administration (FDA) is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma or HSTCL), primarily in adolescents and young adults being treated for Crohn's disease and ulcerative colitis with medicines known as tumor necrosis factor (TNF) blockers, as well as with azathioprine, and/or mercaptopurine.
A meta-analysis of randomized controlled trials (RCTs) supports the use of FDA-approved biological therapies in patients with active Crohn's disease or ulcerative colitis who have failed first- and second-line therapy or who are dependent on corticosteroids, researchers report.
Acne isn't an exclusively teenage problem. It can afflict adults as well, and it's especially problematic among people with IBD taking steroid therapy, which can trigger or aggravate the distressing skin disorder.
People with inflammatory bowel disease (IBD) commonly believe that stress can trigger their symptoms, and a new study suggests they may be right.